Tomiki Hashiyama

806 total citations
32 papers, 649 citations indexed

About

Tomiki Hashiyama is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Tomiki Hashiyama has authored 32 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Organic Chemistry, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Tomiki Hashiyama's work include Cancer Treatment and Pharmacology (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Tomiki Hashiyama is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Microbial Natural Products and Biosynthesis (5 papers). Tomiki Hashiyama collaborates with scholars based in Japan and United States. Tomiki Hashiyama's co-authors include K. Morikawa, K. Barry Sharpless, Mikio Takeda, Pher G. Andersson, Jeonghan Park, H. INOUE, Naoyuki Harada, T. Yamaguchi, K. AOE and Hiroaki Arakawa and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Tomiki Hashiyama

32 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomiki Hashiyama Japan 14 524 181 83 67 66 32 649
Yasunori Kitano Japan 13 460 0.9× 180 1.0× 67 0.8× 43 0.6× 37 0.6× 26 598
Carl H. Behrens United States 9 511 1.0× 251 1.4× 55 0.7× 32 0.5× 43 0.7× 12 642
David R. Kronenthal United States 15 624 1.2× 293 1.6× 92 1.1× 74 1.1× 30 0.5× 24 791
John K. Thottathil United States 13 398 0.8× 274 1.5× 74 0.9× 35 0.5× 50 0.8× 29 564
Marie Jacqueline Luche France 10 364 0.7× 141 0.8× 64 0.8× 56 0.8× 86 1.3× 10 476
Cynthia K. McClure United States 14 629 1.2× 152 0.8× 90 1.1× 59 0.9× 23 0.3× 27 677
Luca Parlanti Italy 10 805 1.5× 215 1.2× 87 1.0× 89 1.3× 42 0.6× 18 925
Andrea Vescovi Germany 9 669 1.3× 262 1.4× 80 1.0× 76 1.1× 37 0.6× 10 844
Jean‐Louis Gras France 14 548 1.0× 224 1.2× 44 0.5× 56 0.8× 31 0.5× 40 669
Tino Rossi Italy 15 488 0.9× 159 0.9× 62 0.7× 45 0.7× 34 0.5× 39 639

Countries citing papers authored by Tomiki Hashiyama

Since Specialization
Citations

This map shows the geographic impact of Tomiki Hashiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomiki Hashiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomiki Hashiyama more than expected).

Fields of papers citing papers by Tomiki Hashiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomiki Hashiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomiki Hashiyama. The network helps show where Tomiki Hashiyama may publish in the future.

Co-authorship network of co-authors of Tomiki Hashiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Tomiki Hashiyama. A scholar is included among the top collaborators of Tomiki Hashiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomiki Hashiyama. Tomiki Hashiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seki, Masahiko, Ritsuo Imashiro, Tooru Kuroda, et al.. (2001). A novel synthesis of a key intermediate for diltiazem. Tetrahedron Letters. 42(46). 8201–8205. 30 indexed citations
2.
Kohno, Jun, et al.. (2001). Structure of TMC-69, a new antitumor antibiotic from Chrysosporium sp. TC 1068. Tetrahedron. 57(9). 1731–1735. 22 indexed citations
3.
Hashiyama, Tomiki. (2000). Applications of Lewis acids for the efficient syntheses of diltiazem, cephems, and taxoids. Medicinal Research Reviews. 20(6). 485–501. 8 indexed citations
4.
Hashiyama, Tomiki, et al.. (2000). Efficient and practical synthesis of both enantiomers of 6-silyloxy-3-pyranone derivatives. Tetrahedron Asymmetry. 11(22). 4529–4535. 15 indexed citations
5.
Yamaguchi, T., Naoyuki Harada, Hiroaki Arakawa, et al.. (1999). Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3′-desphenyl-3′-cyclopropyl analogue of docetaxel. Bioorganic & Medicinal Chemistry Letters. 9(12). 1639–1644. 9 indexed citations
6.
Hashiyama, Tomiki. (1999). An Efficient Method for Preparation of Diltiazem.. Journal of Synthetic Organic Chemistry Japan. 57(5). 394–400. 1 indexed citations
7.
Yamaguchi, T., et al.. (1999). Synthesis of taxoids 4. Novel and versatile methods for preparation of new taxoids by employing cis- or trans-phenyl glycidic acid. Tetrahedron. 55(4). 1005–1016. 20 indexed citations
8.
Hashiyama, Tomiki, et al.. (1998). A Facile Access to 3-Cephems by Employing Novel Lewis Acid Mediated Reaction. Heterocycles. 47(1). 121–121. 3 indexed citations
9.
Hashiyama, Tomiki, Naoyuki Harada, T. Yamaguchi, et al.. (1997). Synthesis of Taxoids II. Synthesis and Antitumor Activity of Water-soluble Taxoids. Heterocycles. 46(1). 241–241. 13 indexed citations
10.
Harada, Naoyuki, et al.. (1997). Synthesis and Antitumor Activity of Quaternary Salts of 2-(2'-Oxoalkoxy)-9-hydroxyellipticines.. Chemical and Pharmaceutical Bulletin. 45(1). 134–137. 5 indexed citations
12.
INOUE, H., Tomiki Hashiyama, Kaoru Takahashi, et al.. (1997). Synthesis and Biological Evaluation of Alkyl, Alkoxy, Alkylthio, or Amino-Substituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones.. Chemical and Pharmaceutical Bulletin. 45(6). 1008–1026. 18 indexed citations
13.
Harada, Naoyuki, et al.. (1996). Synthesis and Biological Activity of O-Alkyl-3-N-aminoacyloxymethyl-5-fluoro-2'-deoxyuridine Derivatives.. Chemical and Pharmaceutical Bulletin. 44(6). 1196–1201. 1 indexed citations
14.
Hashiyama, Tomiki, K. Morikawa, & K. Barry Sharpless. (1993). ChemInform Abstract: α‐Hydroxy Ketones in High Enantiomeric Purity from Asymmetric Dihydroxylation of Enol Ethers.. ChemInform. 24(12). 1 indexed citations
15.
Morikawa, K., Jeonghan Park, Pher G. Andersson, Tomiki Hashiyama, & K. Barry Sharpless. (1993). Catalytic asymmetric dihydroxylation of tetrasubstituted olefins. Journal of the American Chemical Society. 115(18). 8463–8464. 134 indexed citations
16.
INOUE, H., Tomiki Hashiyama, Kaoru Takahashi, et al.. (1991). Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities. Journal of Medicinal Chemistry. 34(2). 675–687. 56 indexed citations
17.
Hashiyama, Tomiki, et al.. (1985). Reaction of 3-phenylglycidic esters. IV. Reaction of methyl 3-(4-methoxyphenyl)glycidate with 2-nitrophenol and synthesis of 1,5-benzoxazepine derivatives.. Chemical and Pharmaceutical Bulletin. 33(2). 634–641. 21 indexed citations
18.
Hashiyama, Tomiki, et al.. (1985). Reaction of 3-phenylglycidic esters. III. Reaction of cis-3-arylglycidic esters with various thiophenols.. Chemical and Pharmaceutical Bulletin. 33(3). 1256–1259. 9 indexed citations
19.
Hashiyama, Tomiki, et al.. (1983). Antiallergic agents. 2. N-(1H-Tetrazol-5-yl)-6-phenyl-2-pyridinecarboxamides. Journal of Medicinal Chemistry. 26(10). 1499–1504. 5 indexed citations
20.
Sekine, Yasuo, et al.. (1982). Studies on antiallergic agents. I. Phenyl-substituted heterocycles with a 5-tetrazolyl or N-(5-tetrazolyl)carbamoyl group.. Chemical and Pharmaceutical Bulletin. 30(12). 4314–4324. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026